课题基金 / 基金详情

Human-Specific Prediction, Training, and Visualization Tools for the Tricuspid Valve from Existing Data

Human-Specific Prediction, Training, and Visualization Tools for the Tricuspid Valve from Existing Data
根据现有数据对三尖瓣进行人体特异性预测、训练和可视化工具
批准号:
10360830
负责人:
MANUEL Karl RAUSCH
金额:
$11.12万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-12-01 至 2023-11-30

项目摘要

项目成果

MANUEL Karl RAUSCH的其他基金

相似基金

相关文献

中文摘要
翻译
摘要。大约有160万美国人患有严重的三尖瓣反流。标准 三尖瓣返流的治疗,手术,是令人震惊的无效与复发性返流, 30%的患者在几年内。我们认为,这些糟糕的结果是由于我们非常有限的基本 了解正常瓣膜功能和瓣膜的潜在、基本疾病和失效机制。 用于预测、训练和可视化的模型在外科手术的许多其他领域中是有价值的,并且可以 是克服我们目前关于三尖瓣知识缺口的关键工具。但几 三尖瓣的现有模型是简化的、群体平均的、非人类特异性的,或者是上述所有的。 为了填补这一明显的工具空白,我们的目标是对以前收集的孤立数据进行二次分析, 跳动的人类心脏基于这些数据,我们将创建完全详细的、人类特定的三尖瓣模型 并将这些模型作为一个开放的预测、训练和可视化工具组合进行管理。本 最后,我们将首先建立人体三尖瓣的详细有限元模型进行预测模拟。 具体来说,我们将建立并验证8名受试者的高保真有限元模型, 瓣环几何形状、瓣叶和腱索机械/显微结构特性以及边界条件均 特定主题。我们将策划这些模型,以兼容广泛流行的,NIH资助的,和开放的- 有限元软件FEBio源码。因为FEBio是一个研究代码,我们将使我们的模型也 与最广泛使用的商业有限元软件之一Abaqus兼容。第二,我们将创造 八个人体三尖瓣的响应模型,用于实时培训模拟。为此我们将 介绍使用线性材料的三尖瓣的低保真度但高效率的计算模型 定律、降维、简化的求解策略和GPU加速。这些模型 将比我们的有限元模型的保真度低,但足够快,可以集成到一个流行的和开放的 用于实时手术模拟软件套件:SOFA。最后,我们还将创建八个增强现实 用于解剖可视化的人体三尖瓣模型。我们将使这些动态和标记的模型 通过增强现实网络界面开放访问,该界面将这些模型作为智能手机托管 为临床医生、患者和工程师提供可访问的资源。一旦我们成功完成这项工作,我们 将创建用于三尖瓣预测建模、培训和可视化的工具。所有的工具都将 知识共享署名-非商业性使用-相同方式共享4.0国际版 执照总之,这些可获得的结果将克服我们目前在三尖瓣方面的工具差距, 解决高度普遍、未满足的临床需求。
英文摘要
ABSTRACT. Roughly 1.6 million Americans suffer from significant tricuspid valve regurgitation. The standard treatment for tricuspid valve regurgitation, surgery, is shockingly ineffective with recurrent regurgitation in up to 30% of patients within a few years. We posit that these poor outcomes are due to our very limited basic understanding of normal valve function and the valve's underlying, fundamental disease and failure mechanisms. Models for prediction, training, and visualization have been valuable in many other areas of surgery and could be critical tools toward overcoming our current knowledge gaps about the tricuspid valve. However, the few existing models of the tricuspid valve are simplified, population-averaged, not human-specific, or all of the above. To fill this clear gap in tools, our goal is to do a secondary analysis on previous data collected on isolated, beating, human hearts. Based on these data, we will create fully-detailed, human-specific tricuspid valve models and curate these models as an openly available portfolio of prediction, training, and visualization tools. To this end, we will first create detailed finite element models of the human tricuspid valve for predictive simulations. Specifically, we will establish and validate high-fidelity finite element models of eight subjects whose leaflet and annular geometries, leaflet and chordae mechanical/microstructural properties, and boundary conditions are all subject-specific. We will curate these models to be compatible with the widely popular, NIH-funded, and open- source finite element software FEBio. Because FEBio is a research code, we will make our models also compatible with one of the most widely-used commercial finite element software, Abaqus. Second, we will create eight responsive models of the human tricuspid valve for real-time training simulations. To this end, we will introduce low-fidelity, but high-efficiency computational models of the tricuspid valve that use linear material laws, dimensional reduction, simplified solution strategies, and GPU acceleration for speed-up. These models will be of lower fidelity than our finite element models, but fast enough to be integrated into a popular and open software suite for real-time surgical simulations: SOFA. Finally, we will also create eight augmented reality models of the human tricuspid valve for anatomic visualization. We will make these dynamic and labelled models openly accessible through an augmented reality web interface that hosts these models as a smart-phone accessible resource for clinicians, patients, and engineers. Once we have successfully concluded this work, we will have created tools for tricuspid valve predictive modeling, training, and visualization. All tools will be made openly available through the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Together, these accessible outcomes will overcome our current tool gap for the tricuspid valve and address a highly prevalent, unmet clinical need.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tricuspid Valve Maladaptation: Its Stimuli, its Effect on Valve Function, and its Response to Therapy
  • 批准号:
    10650421
  • 项目类别:
  • 资助金额:
    $70.03万
  • 财政年份:
    2022
  • 负责人:
    MANUEL Karl RAUSCH
  • 依托单位:
Tricuspid Valve Maladaptation: Its Stimuli, its Effect on Valve Function, and its Response to Therapy
  • 批准号:
    10504140
  • 项目类别:
  • 资助金额:
    $68.69万
  • 财政年份:
    2022
  • 负责人:
    MANUEL Karl RAUSCH
  • 依托单位:
Tricuspid Valve Maladaptation: Its Stimuli, its Effect on Valve Function, and itsResponse to Therapy
  • 批准号:
    10852601
  • 项目类别:
  • 资助金额:
    $19.77万
  • 财政年份:
    2022
  • 负责人:
    MANUEL Karl RAUSCH
  • 依托单位:
Human-Specific Prediction, Training, and Visualization Tools for the Tricuspid Valve from Existing Data
  • 批准号:
    10533351
  • 项目类别:
  • 资助金额:
    $11.11万
  • 财政年份:
    2021
  • 负责人:
    MANUEL Karl RAUSCH
  • 依托单位:
海外基金